These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 38755164)

  • 1. Gut microbiota produces biofilm-associated amyloids with potential for neurodegeneration.
    Fernández-Calvet A; Matilla-Cuenca L; Izco M; Navarro S; Serrano M; Ventura S; Blesa J; Herráiz M; Alkorta-Aranburu G; Galera S; Ruiz de Los Mozos I; Mansego ML; Toledo-Arana A; Alvarez-Erviti L; Valle J
    Nat Commun; 2024 May; 15(1):4150. PubMed ID: 38755164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the Gut Microbiome and Bacterial Amyloids in the Development of Synucleinopathies.
    Trubitsina NP; Matiiv AB; Rogoza TM; Zudilova AA; Bezgina MD; Zhouravleva GA; Bondarev SA
    Biochemistry (Mosc); 2024 Mar; 89(3):523-542. PubMed ID: 38648770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity in gut microbiota drive polyphenol metabolism that influences α-synuclein misfolding and toxicity.
    Ho L; Zhao D; Ono K; Ruan K; Mogno I; Tsuji M; Carry E; Brathwaite J; Sims S; Frolinger T; Westfall S; Mazzola P; Wu Q; Hao K; Lloyd TE; Simon JE; Faith J; Pasinetti GM
    J Nutr Biochem; 2019 Feb; 64():170-181. PubMed ID: 30530257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular interplay between human and bacterial amyloids: Implications in neurodegenerative diseases.
    Jain N
    Biochim Biophys Acta Proteins Proteom; 2024 Jul; 1872(4):141018. PubMed ID: 38641088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crosstalk Between Alpha-Synuclein and Other Human and Non-Human Amyloidogenic Proteins: Consequences for Amyloid Formation in Parkinson's Disease.
    Werner T; Horvath I; Wittung-Stafshede P
    J Parkinsons Dis; 2020; 10(3):819-830. PubMed ID: 32538869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons.
    Pujols J; Peña-Díaz S; Lázaro DF; Peccati F; Pinheiro F; González D; Carija A; Navarro S; Conde-Giménez M; García J; Guardiola S; Giralt E; Salvatella X; Sancho J; Sodupe M; Outeiro TF; Dalfó E; Ventura S
    Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10481-10486. PubMed ID: 30249646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecules disaggregate alpha-synuclein and prevent seeding from patient brain-derived fibrils.
    Murray KA; Hu CJ; Pan H; Lu J; Abskharon R; Bowler JT; Rosenberg GM; Williams CK; Elezi G; Balbirnie M; Faull KF; Vinters HV; Seidler PM; Eisenberg DS
    Proc Natl Acad Sci U S A; 2023 Feb; 120(7):e2217835120. PubMed ID: 36757890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease.
    Sampson TR; Debelius JW; Thron T; Janssen S; Shastri GG; Ilhan ZE; Challis C; Schretter CE; Rocha S; Gradinaru V; Chesselet MF; Keshavarzian A; Shannon KM; Krajmalnik-Brown R; Wittung-Stafshede P; Knight R; Mazmanian SK
    Cell; 2016 Dec; 167(6):1469-1480.e12. PubMed ID: 27912057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson's disease.
    Reyes JF; Ekmark-Léwen S; Perdiki M; Klingstedt T; Hoffmann A; Wiechec E; Nilsson P; Nilsson KPR; Alafuzoff I; Ingelsson M; Hallbeck M
    Acta Neuropathol Commun; 2021 Mar; 9(1):46. PubMed ID: 33743820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic insights into accelerated α-synuclein aggregation mediated by human microbiome-associated functional amyloids.
    Bhoite SS; Han Y; Ruotolo BT; Chapman MR
    J Biol Chem; 2022 Jul; 298(7):102088. PubMed ID: 35654142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophagy in Synucleinopathy: The Overwhelmed and Defective Machinery.
    Arotcarena ML; Teil M; Dehay B
    Cells; 2019 Jun; 8(6):. PubMed ID: 31181865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut power: Modulation of human amyloid formation by amyloidogenic proteins in the gastrointestinal tract.
    Wittung-Stafshede P
    Curr Opin Struct Biol; 2022 Feb; 72():33-38. PubMed ID: 34450484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α-Synucleinopathy associated c-Abl activation causes p53-dependent autophagy impairment.
    Karim MR; Liao EE; Kim J; Meints J; Martinez HM; Pletnikova O; Troncoso JC; Lee MK
    Mol Neurodegener; 2020 Apr; 15(1):27. PubMed ID: 32299471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The link between the gut microbiota and Parkinson's Disease: A systematic mechanism review with focus on α-synuclein transport.
    Nielsen SD; Pearson NM; Seidler K
    Brain Res; 2021 Oct; 1769():147609. PubMed ID: 34371014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with structurally adapted fungal protein fibrils induces immunity to Parkinson's disease.
    Pesch V; Flores-Fernandez JM; Reithofer S; Ma L; Özdüzenciler P; Busch Y; Sriraman A; Wang Y; Amidian S; Kroepel CVM; Müller L; Lien Y; Rudtke O; Frieg B; Schröder GF; Wille H; Tamgüney G
    Brain; 2024 May; 147(5):1644-1652. PubMed ID: 38428032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α-Synuclein pathology in Parkinson's disease and related α-synucleinopathies.
    Henderson MX; Trojanowski JQ; Lee VM
    Neurosci Lett; 2019 Sep; 709():134316. PubMed ID: 31170426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut-to-brain spreading of pathology in synucleinopathies: A focus on molecular signalling mediators.
    Schmitt V; Masanetz RK; Weidenfeller M; Ebbinghaus LS; Süß P; Rosshart SP; von Hörsten S; Zunke F; Winkler J; Xiang W
    Behav Brain Res; 2023 Aug; 452():114574. PubMed ID: 37423320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. REST Protects Dopaminergic Neurons from Mitochondrial and α-Synuclein Oligomer Pathology in an Alpha Synuclein Overexpressing BAC-Transgenic Mouse Model.
    Ryan BJ; Bengoa-Vergniory N; Williamson M; Kirkiz E; Roberts R; Corda G; Sloan M; Saqlain S; Cherubini M; Poppinga J; Bogtofte H; Cioroch M; Hester S; Wade-Martins R
    J Neurosci; 2021 Apr; 41(16):3731-3746. PubMed ID: 33563726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-Synuclein filaments from transgenic mouse and human synucleinopathy-containing brains are major seed-competent species.
    Morgan SA; Lavenir I; Fan J; Masuda-Suzukake M; Passarella D; DeTure MA; Dickson DW; Ghetti B; Goedert M
    J Biol Chem; 2020 May; 295(19):6652-6664. PubMed ID: 32209651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant pro-CTSD (cathepsin D) enhances SNCA/α-Synuclein degradation in α-Synucleinopathy models.
    Prieto Huarcaya S; Drobny A; Marques ARA; Di Spiezio A; Dobert JP; Balta D; Werner C; Rizo T; Gallwitz L; Bub S; Stojkovska I; Belur NR; Fogh J; Mazzulli JR; Xiang W; Fulzele A; Dejung M; Sauer M; Winner B; Rose-John S; Arnold P; Saftig P; Zunke F
    Autophagy; 2022 May; 18(5):1127-1151. PubMed ID: 35287553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.